Vaccine Manufacture and Supply – News and Features

Cameroon today launched the RTS,S malaria vaccine into its routine national immunization services, becoming the first country to do so outside the malaria vaccine pilot programme that was carried out in Ghana, Kenya and Malawi.

A newly developed vaccine could offer an inexpensive way to lower "bad" cholesterol, improving heart health.

The first national study of its kind suggests that most US parents plan to vaccinate their children against influenza, COVID-19 and respiratory syncytial virus.

This article explores how biopharmaceutical organizations seeking to remain competitive must adopt innovations, like cell-free long DNA synthesis, to unleash the potential of synthetic biology and accelerate therapeutic development.

Drew Burch discusses how next-gen mRNA technology is one of the most valuable tools to combat and control disease outbreaks and why continued investment in this field is crucial for maintaining our pandemic preparedness.

This article will outline how automation is currently adopted in vaccine development, including workflows and methods to improve efficiency. In addition, it will explore future opportunities to implement automation when developing vaccines.

The International Vaccine Institute (IVI) began clinical development of DuoChol, a new low-cost oral cholera vaccine (OCV) in capsule form.

A mobile vaccine printer, developed by MIT researchers, could be used to scale up vaccine production and help vaccines reach more people.

With the world of science rapidly evolving, and a new year beginning, we look at the trends breaking through right now, asking experts: where is the world of science headed?

This article will explore some of the key challenges associated with vaccine storage and why this differs across different types of vaccines.